Financhill
Buy
62

SPNS Quote, Financials, Valuation and Earnings

Last price:
$43.29
Seasonality move :
6.33%
Day range:
$43.28 - $43.30
52-week range:
$23.69 - $43.36
Dividend yield:
1.36%
P/E ratio:
37.79x
P/S ratio:
4.31x
P/B ratio:
4.71x
Volume:
227.3K
Avg. volume:
401.7K
1-year change:
56.23%
Market cap:
$2.4B
Revenue:
$542.4M
EPS (TTM):
$1.15

Analysts' Opinion

  • Consensus Rating
    Sapiens International Corp. NV has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
  • Price Target Downside
    According to analysts' consensus price target of $37.25, Sapiens International Corp. NV has an estimated downside of -13.95% from its current price of $43.29.
  • Price Target Upside
    According to analysts, the highest upside price target is $43.50 representing -100% upside increase from its current price of $43.29.

Fair Value

  • According to the consensus of 3 analysts, Sapiens International Corp. NV has -13.95% downside to fair value with a price target of $37.25 per share.

SPNS vs. S&P 500

  • Over the past 5 trading days, Sapiens International Corp. NV has overperformed the S&P 500 by 0.32% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Sapiens International Corp. NV does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Sapiens International Corp. NV has grown year-over-year revenues for 65 quarters straight. In the most recent quarter Sapiens International Corp. NV reported revenues of $152.3M.

Earnings Growth

  • Sapiens International Corp. NV earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Sapiens International Corp. NV reported earnings per share of $0.25.
Enterprise value:
2.4B
EV / Invested capital:
4.20x
Price / LTM sales:
4.31x
EV / EBIT:
28.20x
EV / Revenue:
4.24x
PEG ratio (5yr expected):
1.84x
EV / Free cash flow:
33.33x
Price / Operating cash flow:
33.84x
Enterprise value / EBITDA:
23.38x
Gross Profit (TTM):
$256.5M
Return On Assets:
9.05%
Net Income Margin (TTM):
11.46%
Return On Equity:
13.12%
Return On Invested Capital:
11.87%
Operating Margin:
11.96%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $503.2M $538.9M $564.3M $137M $152.3M
Gross Profit $219.7M $240M $256.5M $61.8M $69M
Operating Income $75.3M $85.4M $84.9M $22.5M $18.2M
EBITDA $92.4M $101.9M $102.5M $26.1M $23.3M
Diluted EPS $1.06 $1.27 $1.15 $0.33 $0.25
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $275.4M $269.1M $290.4M $321.4M $251.8M
Total Assets $699.9M $642.2M $650.2M $683.3M $743.7M
Current Liabilities $151.4M $143.3M $139.6M $147.3M $166M
Total Liabilities $309M $264.9M $230.4M $212M $216.5M
Total Equity $390.9M $377.2M $419.8M $471.3M $527.2M
Total Debt $152.7M $108.4M $80.3M $57.1M $37.2M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $53.2M $77.1M $81.9M $13.1M $12.2M
Cash From Investing -$62.2M $14.4M -$79.2M $21.2M $4.9M
Cash From Financing -$41.5M -$49.1M -$62.8M -$14.3M -$2.3M
Free Cash Flow $44.4M $67.6M $71.9M $10.1M $9.8M
SPNS
Sector
Market Cap
$2.4B
$55.5M
Price % of 52-Week High
99.84%
58.81%
Dividend Yield
1.36%
0%
Shareholder Yield
2.37%
0.01%
1-Year Price Total Return
56.23%
-11.41%
Beta (5-Year)
0.887
0.674
Dividend yield:
1.36%
Annualized payout:
$0.57
Payout ratio:
--
Growth streak:
1 years

Technicals

8-day SMA
Buy
Level $43.19
200-day SMA
Buy
Level $33.98
Bollinger Bands (100)
Buy
Level 34.1 - 45.9
Chaikin Money Flow
Buy
Level 14.3M
20-day SMA
Buy
Level $43.17
Relative Strength Index (RSI14)
Buy
Level 65.60
ADX Line
Buy
Level 44.04
Williams %R
Sell
Level -16.6667
50-day SMA
Buy
Level $43.10
MACD (12, 26)
Buy
Level 0.08
25-day Aroon Oscillator
Buy
Level 16
On Balance Volume
Neutral
Level 67.9M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (6.1147)
Buy
CA Score (Annual)
Level (1.2248)
Buy
Beneish M-Score (Annual)
Level (-2.4647)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-1.9151)
Buy
Piotroski F Score (Annual)
Level (9)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (10)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Sapiens International Corp. NV provides software solutions for the insurance industry. It offers core, end-to-end solutions to the global general insurance, property and casualty, life, pension and annuities, reinsurance and retirement markets, as well as business decision management software. The company was founded by Joseph Bolless and Ron Zuckerman in 1982 and is headquartered in Holon, Israel.

Stock Forecast FAQ

In the current month, SPNS has received 0 Buy ratings 3 Hold ratings, and 0 Sell ratings. The SPNS average analyst price target in the past 3 months is $37.25.

  • Where Will Sapiens International Corp. NV Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Sapiens International Corp. NV share price will drop to $37.25 per share over the next 12 months.

  • What Do Analysts Say About Sapiens International Corp. NV?

    Analysts are divided on their view about Sapiens International Corp. NV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sapiens International Corp. NV is a Sell and believe this share price will rise from its current level to $31.00.

  • What Is Sapiens International Corp. NV's Price Target?

    The price target for Sapiens International Corp. NV over the next 1-year time period is forecast to be $37.25 according to 3 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.

  • Is SPNS A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Sapiens International Corp. NV is a Hold. 3 of 3 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of SPNS?

    You can purchase shares of Sapiens International Corp. NV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sapiens International Corp. NV shares.

  • What Is The Sapiens International Corp. NV Share Price Today?

    Sapiens International Corp. NV was last trading at $43.29 per share. This represents the most recent stock quote for Sapiens International Corp. NV. Yesterday, Sapiens International Corp. NV closed at $43.29 per share.

  • How To Buy Sapiens International Corp. NV Stock Online?

    In order to purchase Sapiens International Corp. NV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
64
Is AAPL Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 38x

Buy
69
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
47
PSTG alert for Dec 4

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
41
SMX alert for Dec 4

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
43
HY alert for Dec 4

Hyster-Yale, Inc. [HY] is up 1.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock